UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis

Nature medicine, 2008-08, Vol.14 (8), p.843-848

2008

Volltextzugriff (PDF)

Merlin and the ERM proteins in Schwann cells, neurons and growth cones

Nature reviews. Neuroscience, 2004-06, Vol.5 (6), p.462-470

Ramesh, Vijaya

2004

Volltextzugriff (PDF)

High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy

Scientific reports, 2021-08, Vol.11 (1), p.17029-17029, Article 17029

2021

Volltextzugriff (PDF)

NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

Molecular and Cellular Biology, 2009-08, Vol.29 (15), p.4250-4261

2009

Volltextzugriff (PDF)

Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma

Scientific reports, 2020-03, Vol.10 (1), p.4211-4211, Article 4211

2020

Volltextzugriff (PDF)

TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling

Molecular autism, 2020-01, Vol.11 (1), p.2-2, Article 2

2020

Volltextzugriff (PDF)

Functions of MUC16 in Corneal Epithelial Cells

Investigative ophthalmology & visual science, 2007-10, Vol.48 (10), p.4509-4518

2007

Volltextzugriff (PDF)

Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations

Molecular autism, 2023-10, Vol.14 (1), p.39-39, Article 39

2023

Volltextzugriff (PDF)

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

Molecular therapy. Methods & clinical development, 2024-06, Vol.32 (2), p.101262, Article 101262

2024

Volltextzugriff (PDF)

A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas

Oncotarget, 2015-07, Vol.6 (19), p.16981-16997

2015

Volltextzugriff (PDF)

Air-dried 3D-collagen-chitosan biocomposite scaffold for tissue engineering application

Polymer composites, 2012-11, Vol.33 (11), p.2029-2035

2012

Volltextzugriff (PDF)

Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model

Neurobiology of disease, 2015-10, Vol.82, p.22-31

2015

Volltextzugriff (PDF)

Admixture Mapping of an Allele Affecting Interleukin 6 Soluble Receptor and Interleukin 6 Levels

American journal of human genetics, 2007-04, Vol.80 (4), p.716-726

2007

Volltextzugriff (PDF)

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

Molecular therapy. Methods & clinical development, 2022-09, Vol.26, p.169-180

2022

Volltextzugriff (PDF)

Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency

PloS one, 2015-10, Vol.10 (10), p.e0140192

2015

Volltextzugriff (PDF)

Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas

Clinical cancer research, 2009-03, Vol.15 (6), p.1940-1946

2009

Volltextzugriff (PDF)

Role of NHERF1, Cystic Fibrosis Transmembrane Conductance Regulator, and cAMP in the Regulation of Aquaporin 9

The Journal of biological chemistry, 2008-02, Vol.283 (5), p.2986-2996

2008

Volltextzugriff (PDF)

Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin

Science advances, 2021-01, Vol.7 (2)

2021

Volltextzugriff (PDF)

Association of Mammalian Trp4 and Phospholipase C Isozymes with a PDZ Domain-containing Protein, NHERF

The Journal of biological chemistry, 2000-12, Vol.275 (48), p.37559-37564

2000

Volltextzugriff (PDF)

Assessment of Immunomodulatory Activity of Euphorbia hirta L

Indian journal of pharmaceutical sciences, 2010-09, Vol.72 (5), p.621-625

2010

Volltextzugriff (PDF)

Pam (Protein associated with Myc) functions as an E3 Ubiquitin ligase and regulates TSC/mTOR signaling

Cellular signalling, 2008-06, Vol.20 (6), p.1084-1091

2008

Volltextzugriff (PDF)

Survey of Somatic Mutations in Tuberous Sclerosis Complex (TSC) Hamartomas Suggests Different Genetic Mechanisms for Pathogenesis of TSC Lesions

American journal of human genetics, 2001-09, Vol.69 (3), p.493-503

2001

Volltextzugriff (PDF)

TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion

Neurobiology of disease, 2003-02, Vol.12 (1), p.11-24

2003

Volltextzugriff (PDF)

The Early Onset Dystonia Protein TorsinA Interacts with Kinesin Light Chain 1

The Journal of biological chemistry, 2004-05, Vol.279 (19), p.19882-19892

2004

Volltextzugriff (PDF)

1 – 25 von 552

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(433)
Mit Volltextzugriff
(474)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis

Merlin and the ERM proteins in Schwann cells, neurons and growth cones

High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathy

NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma

TSC patient-derived isogenic neural progenitor cells reveal altered early neurodevelopmental phenotypes and rapamycin-induced MNK-eIF4E signaling

Functions of MUC16 in Corneal Epithelial Cells

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2

Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas

Air-dried 3D-collagen-chitosan biocomposite scaffold for tissue engineering application

Survival benefit and phenotypic improvement by hamartin gene therapy in a tuberous sclerosis mouse brain model

Admixture Mapping of an Allele Affecting Interleukin 6 Soluble Receptor and Interleukin 6 Levels

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency

Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas

Role of NHERF1, Cystic Fibrosis Transmembrane Conductance Regulator, and cAMP in the Regulation of Aquaporin 9

Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin

Association of Mammalian Trp4 and Phospholipase C Isozymes with a PDZ Domain-containing Protein, NHERF

Assessment of Immunomodulatory Activity of Euphorbia hirta L

Pam (Protein associated with Myc) functions as an E3 Ubiquitin ligase and regulates TSC/mTOR signaling

Survey of Somatic Mutations in Tuberous Sclerosis Complex (TSC) Hamartomas Suggests Different Genetic Mechanisms for Pathogenesis of TSC Lesions

TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion

The Early Onset Dystonia Protein TorsinA Interacts with Kinesin Light Chain 1

Suchergebnisse filtern